Cosopt and Ipratropium bromide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cosopt (dorzolamide hydrochloride; timolol maleate) and Ipratropium bromide (ipratropium bromide). Common drug interactions include haemorrhoids among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Cosopt and Ipratropium bromide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Cosopt?

Cosopt has active ingredients of dorzolamide hydrochloride; timolol maleate. It is often used in glaucoma. eHealthMe is studying from 9,029 Cosopt users. Check the latest studies of Cosopt.

What is Ipratropium bromide?

Ipratropium bromide has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 17,965 Ipratropium bromide users. Check the latest studies of Ipratropium bromide.



On Jul, 11, 2026

11 people who take Cosopt and Ipratropium bromide together, and have interactions are studied.

Cosopt and Ipratropium bromide drug interactions.

What are the common drug interactions of Cosopt and Ipratropium Bromide, by gender? *:

female:

  1. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  2. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  3. Leukopenia (less number of white blood cells in blood)
  4. Low turnover osteopathy (slow removal of old bone and its replacement by new bone)
  5. Lung disorder (lung disease)
  6. Normochromic normocytic anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits)
  7. Umbilical hernia (an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the belly button)
  8. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  9. Pain
  10. Renal cyst (kidney cyst)

male:

  1. Cardiac failure congestive
  2. Death
  3. Pneumonia
  4. Rash papular (redness with papule)
  5. Respiratory disorder (respiratory disease)
  6. Rhinorrhoea (watery mucus discharge from the nose)
  7. Vomiting
  8. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  9. Postoperative wound complication
  10. Pulmonary oedema (fluid accumulation in the lungs)

What are the common drug interactions of Cosopt and Ipratropium Bromide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Cardiac failure congestive
  2. Death
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  5. Cough
  6. Depression
  7. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  8. Fall
  9. Femur fracture
  10. Gastritis (inflammation of stomach)

What are the existing conditions these people have? *

  1. Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 3 people, 27.27%
  2. Type 2 Diabetes: 2 people, 18.18%
  3. High Blood Pressure: 2 people, 18.18%
  4. Breast Cancer Metastatic: 2 people, 18.18%
  5. Pneumonia Staphylococcal (pneumonia staphylococcal infections are usually caused by the organism staphylococcus aureus): 1 person, 9.09%
  6. Pneumonia: 1 person, 9.09%
  7. Osteoporosis (bones weak and more likely to break): 1 person, 9.09%
  8. Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 9.09%
  9. Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 1 person, 9.09%
  10. Multiple Myeloma (cancer of the plasma cells): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Cosopt and Ipratropium bromide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cosopt and Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cosopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ipratropium bromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cosopt and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ipratropium bromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dorzolamide hydrochloride; timolol maleate and ipratropium bromide (the active ingredients of Cosopt and Ipratropium bromide, respectively), and Cosopt and Ipratropium bromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: